ORIC Pharmaceuticals, Inc. (ORIC) Secures $125M to Advance ORIC-944 Phase 3 Trials
These robust responses were seen across all dose levels and with both apalutamide and darolutamide combinations. Most patients remain on therapy, with several approaching one year or more of treatment.
A scientist examining cells in a lab, representing the company's dedication to developing specialty pharmaceuticals.
Safety data were also encouraging: the vast majority of adverse events were mild or moderate (Grade 1 or 2), primarily gastrointestinal, supporting long-term dosing suitability. Only one patient experienced a Grade 3 event, and there were no severe (Grade 4 or 5) treatment-related adverse events. ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) plans to advance two recommended Phase 2 doses for each combination into further study, with a global Phase 3 trial set to begin in the first half of 2026.
To support these efforts, ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) announced a $125 million private placement financing led by top healthcare investors, extending its cash runway into the second half of 2027 and through the anticipated Phase 3 trial readout.
While we acknowledge the potential of ORIC to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ORIC and that has 100x upside potential, check out our report about this
READ NEXT: and
Disclosure: None.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Bausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease Treatment
Bausch Health Companies Inc. (NYSE:BHC) is one of the most undervalued Canadian stocks to buy now. On July 29, Bausch Health Companies announced a definitive agreement to acquire DURECT Corporation (NASDAQ:DRRX). The acquisition is valued at ~$63 million upfront with potential for an additional $350 million in sales milestone payments, and will be an all-cash transaction. Bausch Health is acquiring DURECT primarily for its lead asset, called larsucosterol. This novel therapeutic molecule is an epigenetic modulator that the FDA has granted Breakthrough Therapy Designation for the treatment of alcoholic hepatitis/AH, which is a life-threatening form of alcohol-associated liver disease. A closeup of pills in a pharmacy, representing the high quality medications of the company. AH is characterized by severe liver inflammation & necrosis and accounted for ~164,000 hospital admissions in the US in 2021. There are currently no FDA or European Medicines Agency/EMA-approved treatments for the condition. The acquisition of larsucosterol strengthens Bausch Health's commitment to hepatology. Bausch Health plans to use its expertise to advance larsucosterol through a planned Phase 3 program. Bausch Health Companies Inc. (NYSE:BHC) is a diversified specialty pharmaceutical and medical device company that develops, manufactures, and markets products in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, OTC products, aesthetic medical devices, and eye health. DURECT Corporation (NASDAQ:DRRX) is a late-stage biopharmaceutical company that develops epigenetic therapies that target dysregulated DNA methylation to transform the treatment of serious and life-threatening conditions, such as acute organ injury. While we acknowledge the potential of BHC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.
Associated Press
21 minutes ago
- Associated Press
Dreamers & Founders Reshapes the Future of Youth Education with Global Entrepreneurship Program
Dreamers & Founders, founded by Kayshree Govender, is revolutionizing youth education by teaching real-world skills through entrepreneurship, leadership, and AI to children worldwide. Global, August 9, 2025 -- A Story Rooted in Resilience In a world where digital transformation is rapidly reshaping industries and communities, Dreamers & Founders, founded by South African entrepreneur Kayshree Govender, is leading a global movement to redefine youth education. The platform goes beyond traditional learning by giving children aged 8 to 18 the tools, confidence, and skills to thrive in an ever-changing world. Govender's story is one of profound resilience. After losing her mother to cancer and enduring a challenging divorce that left her financially strained, Govender found herself facing significant adversity as a single parent. However, rather than letting these challenges define her, she turned her pain into a purpose. Determined to provide her son and other children with the opportunities she lacked growing up, she created Dreamers & Founders — a platform that would empower children to become leaders, thinkers, and builders in the real world. Not Just Business — A Blueprint for Life Dreamers & Founders is not just another online program. It is a revolution in how children learn. Through age-appropriate and gamified learning, the platform helps children develop vital skills in entrepreneurship, leadership, and emotional intelligence. The program offers two main tracks designed to cater to different age groups and levels of experience: What makes the program truly unique is its focus on not just business but life skills. Dreamers & Founders encourages resilience, problem-solving, and effective communication in ways that keep kids engaged and excited. The platform integrates real-world applications of these skills, teaching children how to create value, solve problems, and lead with empathy. Success stories from participants abound. In the UK, a 10-year-old girl turned her hobby into a thriving skincare brand. In the U.S., a teenager transitioned from a casual gamer to an entrepreneur in just three months. South African students have even begun hosting youth business talks, inspiring others to take action and create their own ventures. The Pain Parents Feel — and the Promise of What's Possible As children become increasingly absorbed in screens and uncertain about their futures, many parents feel disconnected from the educational systems that are supposed to prepare their children for life beyond school. Govender regularly hears from parents who are concerned: 'My child has lost their spark,' or 'I want them to have options, but I don't know how to give it to them.' Dreamers & Founders was built to answer these concerns. The platform combines cutting-edge tools like AI and pitch training with timeless values of leadership, empathy, and courage. This approach creates a learning environment where children develop practical skills and confidence that will serve them throughout their lives. Through personalized coaching and innovative learning strategies, Dreamers & Founders offers a transformative experience for kids, empowering them to navigate an uncertain future with clarity and purpose. Award-Winning, Mission-Driven, Globally Relevant The impact of Dreamers & Founders has not gone unnoticed. In 2025, the program was honored with the prestigious Evergreen Award for Best Educational Program for Kids in Business & Financial Literacy. This recognition celebrates the platform's innovative curriculum, real-world impact, and commitment to preparing the next generation for leadership roles in the global economy. Dreamers & Founders now operates in over a dozen countries, with students enrolled from the USA, UK, UAE, Australia, and beyond. The program's global reach demonstrates the universal need for a new approach to education—one that is rooted in real-world application and prepares kids for the challenges ahead. Beyond the classroom, Dreamers & Founders reinvests in underserved communities. A portion of every enrollment goes toward funding educational infrastructure and initiatives in African schools, ensuring that the program's benefits are felt in the communities that need it most. 'This is about creating a ripple effect,' says Govender. 'One confident child becomes a confident leader, and that changes families, schools, and communities.' Not Just a Program — A Movement Dreamers & Founders is more than just a program — it is a movement. The platform has built a thriving community of parents, mentors, and educators who share the vision of a future where children are empowered to lead and innovate. Through initiatives like the Founders Circle and Parent Power Pass, families gain access to resources that support their child's entrepreneurial journey and development. As one parent shared: 'It's not just about business. My child became more focused, confident, and expressive. That's the real win.' This shift in how we view education — from passive learning to active leadership and problem-solving — is what has driven the momentum of Dreamers & Founders. It is a movement that emphasizes the importance of equipping children with not just knowledge, but with the confidence and tools to change the world. About Dreamers & Founders Dreamers & Founders is a global youth entrepreneurship and leadership program designed for children ages 8–18. Through age-personalized coaching, gamified learning, and ethical AI education, the platform empowers young people to launch businesses, develop confidence, and gain real-world skills. Founded in South Africa and now operating worldwide, Dreamers & Founders is committed to providing a family-integrated solution for the future of education. Media Contact Kayshree Govender Founder, Dreamers and Founders Email: [email protected] Website: Social: Facebook | Instagram | TikTok Contact Info: Name: Kayshree Govender Email: Send Email Organization: Dreamers & Founders Website: Release ID: 89166786 Should any problems, inaccuracies, or doubts arise from the content contained within this press release, we kindly request that you inform us immediately by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will promptly address your concerns within 8 hours, taking necessary steps to rectify identified issues or assist with the removal process. Providing accurate and dependable information is at the core of our commitment to our readers.
Associated Press
37 minutes ago
- Associated Press
LINE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Lineage, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK - August 8, 2025 ( NEWMEDIAWIRE ) - Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lineage, Inc. ('Lineage' or 'the Company') (NASDAQ: LINE) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Lineage securities pursuant to the registration statement and prospectus issued in connection with the Company's July 2024 initial public offering ('IPO'). Such investors are encouraged to join this case by visiting the firm's site: Case Details On June 26, 2024, Lineage filed a registration statement for the IPO on Form S-11 with the SEC which, after amendments, was declared effective on July 24, 2024 (the 'Registration Statement'). On July 26, 2024, Lineage filed a prospectus for the IPO on Form 424B4 with the SEC, which was incorporated into and formed part of the Registration Statement. The complaint alleges that the Registration Statement contained material misrepresentations about Lineage's business, historical financial results, and the industry trends purportedly facing the Company at the time of the IPO. Specifically, the Registration Statement stated that the lingering effects of the COVID-19 pandemic had 'accelerated trends that had a marked short-term impact on cold storage demand and have the potential to be growth engines for the industry in coming years' after the IPO. In truth, Lineage was in the midst of a sustained downturn, as the Company's customers not only destocked excessive inventory built up during the COVID-19 pandemic, but also shifted to the maintenance of leaner inventories on a go-forward basis and as more cold-storage supply came on line, with Lineage suffering particularly negative effects in terms of occupancy rates and pricing power due to its recent imposition of unsustainable price increases amongst its customer base. Since the IPO approximately one year ago, the price of Lineage stock has fallen to lows near $40 per share - approximately half the IPO price. What's Next? A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. If you suffered a loss in Lineage you have until September 30, 2025, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. There is No Cost to You We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful. Why Bronstein, Gewirtz & Grossman Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. Follow us for updates on LinkedIn, X, Facebook, or Instagram. Attorney advertising. Prior results do not guarantee similar outcomes. Contact Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Nathan Miller 332-239-2660 | [email protected] View the original release on
